Robert F. Kennedy Jr. sought Marshall as an alternative during FDA leadership uncertainty

White House officials are weighing whether to allow Dr. Heidi Overton’s nomination to lead the FDA to fail in committee or mount a robust effort to support her bid, people familiar with the matter said. Overton likely needs the support of every Republican on the Senate health panel to advance to a full Senate vote. The White House and Overton did not respond to requests for comment.

Overton is scheduled for a committee vote Wednesday. Several Republican lawmakers on the panel have expressed concern about her support for rolling back vaccine recommendations, her role in loosening restrictions on vapes and her stance on abortion policy. Overton currently helps lead the White House’s Domestic Policy Council.

Sen. Bill Cassidy of Louisiana called Overton’s vaccine stance “almost disqualifying” in August. Republicans Susan Collins of Maine and Lisa Murkowski of Alaska have previously taken issue with the Trump administration’s approach to vaccines. Overton drafted President Trump’s August executive order recommending that children receive fewer immunizations, people familiar with the matter said. Many medical and scientific organizations have called the order scientifically unjustified.

Cassidy said last week that he was still undecided about Overton and on Sunday told CBS’s “Face the Nation” that he still had questions. A person familiar with his thinking said Tuesday that Cassidy remained undecided, though he was also concerned about the FDA being led by a series of acting commissioners.

Health Secretary Robert F. Kennedy Jr. reached out to Sen. Roger Marshall (R., Kan.) about taking Overton’s place, a person familiar with the matter said. News website Semafor had earlier reported that Marshall was under consideration, and a spokeswoman for Marshall declined to comment. Marshall, an obstetrician, recently lost what was historically a safe Senate seat for Republicans to Democrat Adam Hamilton, a pastor.

Marshall chairs the Senate’s Make America Healthy Again caucus but has not won broad support from the MAHA movement because of his support for the pesticide glyphosate.

At Overton’s confirmation hearing in September, Collins voiced concern about the White House’s embrace of flavored vaping. Overton defended the FDA’s recent signoffs on new flavored products, saying they met the legal standard for protecting public health. She also said she shared Collins’ desire to keep children away from the products.

Overton has written that the abortion pill is “dangerous.” Antiabortion advocates have grown disappointed that the Trump administration, in which she helps lead domestic policy, approved a generic form of the pill while declining to roll back telehealth access to the pills. Those decisions triggered concerns from Sen. Josh Hawley of Missouri, who opposes broad access to the pills.

On Tuesday, Hawley said he was pleased with Overton’s recent answers about her plan for the FDA’s current study of abortion-pill safety, though he was still reading what she sent. “Every commitment I asked her to give, she made,” he said. “It was a pretty fulsome response.” At her confirmation hearing, Overton said the pill had been approved by the FDA as safe and effective and that she would not prejudge the outcome of the FDA’s current study on its safety.

President Trump nominated Overton after pushing out his previous FDA commissioner, Dr. Marty Makary. The FDA is currently being led by lawyer Kyle Diamantas on an acting basis, and he is expected to leave his post by the end of the year, people familiar said. If Diamantas leaves before Overton or another nominee is confirmed, officials are considering temporarily installing Dr. Sara Brenner, a senior counselor at the Department of Health and Human Services who works on public-health issues including Ebola and pandemic preparedness.

Signs reading “Say no to Heidi Vaperton” appeared around Washington, D.C., over the weekend to oppose Overton’s nomination. Health in Office, which identifies itself as a group of private citizens, paid for the signs, spokeswoman Jenny Kay said. The signs were placed in Anchorage, Alaska; Baton Rouge, Louisiana; and cities in Maine. Kay said the group is worried about Overton’s stance on vaping and vaccines and is concerned about her opposition to the abortion pill.

Susan B. Anthony Pro-Life America has come out against Overton’s nomination on different grounds. The group says she is not opposed enough to the abortion pill and has not committed to rolling back telehealth access to the pill. It wants the federal government to restore requirements that the abortion pill be dispensed in person by a doctor.

Other antiabortion activists have praised Overton’s nomination, while the Department of Health and Human Services did not respond to requests for comment. “The administration, under Dr. Overton’s oversight, has refused to stop the flood of abortion drugs into pro-life states and into the hands of predators who seek to coerce or poison women with these drugs,” Dannenfelser said.

Overton remains scheduled for a Wednesday committee vote and still likely needs support from every Republican on the health panel to advance to the full Senate. The administration is still weighing whether to withdraw her nomination.